<DOC>
	<DOCNO>NCT00312897</DOCNO>
	<brief_summary>Aim . To provide preliminary data efficacy omega-3FA treatment adolescent MDD . To address aim , 10-week double blind , placebo-controlled study omega-3FA , use flexible dose titration propose . Primary outcome measure : ( 1 ) change total score Children 's Depression Rating Scale-Revised ( CDRS-R ) end treatment ( 2 ) response rate Clinical Global Improvement scale ( CGI ) end 10-week treatment . Hypothesis . Omega-3FA treatment adolescent MDD result significant reduction CDRS-R total score , significantly high improvement rate CGI end treatment compare placebo .</brief_summary>
	<brief_title>Omega-3 Fatty Acids Adolescent Depression</brief_title>
	<detailed_description>Title : Omega-3 Fatty Acids Adolescents Depression NOTE : No individual advise terminate ongoing treatment . If adolescent psychotherapy prior entry study , allow continue treatment . However , psychotherapy initiated time entry study . Aim : To provide preliminary clinical data efficacy omega-3FA ( derived fish oil ) treatment adolescent MDD . A NCCAM/NIH-funded study . Summary : Informed consent obtain parent/guardian assent obtain participant . Interested participant free diagnostic evaluation study psychiatrist determine eligibility . Routine blood test urine pregnancy test obtain . Eligible participant randomize receive either omega-3FA matching placebo ( corn oil ) 10 week . Patients see weekly throughout trial . Dosage titrate base clinical response side effect . At end double-blind phase , participant refer clinician informed subject ' treatment . Depending treatment receive double-blind phase , post-study treatment option include treatment omega-3 fatty acid SSRI .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Age : 1219 Depressed DSMIV diagnosis MDD Duration depressive episode great 6 week Current past DSMIVTR bipolar , schizophrenia , psychosis , pervasive developmental disorder ( PDD ) , Tourette 's disorder . Current diagnosis eating , panic , conduct , obsessive compulsive , post traumatic stress , and/or substancerelated disorder ( nicotine ) . Adolescents present current suicidal ideation intent plan , may pose danger . Current antidepressant treatment , take within 60 day prior enrollment Neuroleptics take within 90 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Adolescents</keyword>
	<keyword>Depression</keyword>
	<keyword>Fish Oil</keyword>
	<keyword>Omega-3 Fatty Acids</keyword>
	<keyword>Psychiatry</keyword>
</DOC>